Project Grant R01CA293995
Award Date
7/1/24
Completion Date
6/30/29
Dollars Obligated
$711K
Federal Agency
National Cancer Institute
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
Loma Linda, CA 92354, USA
Similar Awards
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $550,296 to develop a multimodal imaging-based diagnostic system for accurately assessing the risk of precancerous oral lesions. The key products/services to be delivered include: Development of machine learning (ML) and deep learning (DL) models using Fourier transform infrared (FTIR) imaging to stratify oral...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund research to develop a machine learning-based model that can accurately predict the presence of aggressive tissue phenotypes in head and neck squamous cell carcinoma (HNSCC). The $168,610 award, effective from April 2025 to March 2028, will be led by Dr. Yingci Liu at Rutgers, The State University of New Jersey. The...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $505,613 to the Fred Hutchinson Cancer Center in Seattle, WA to develop statistical and computational approaches that leverage genomic data to enable precision cancer prevention. The key objectives are to: (1) Create deep learning-based methods to identify tumor subtypes associated with poor outcomes, and integrate external biomarker data to...
This Project Grant award, valued at $496,567 and awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) on June 1, 2024, will support research to develop, validate, and implement advanced computational tumor phenotyping techniques to characterize head and neck squamous cell carcinoma (HNSCC) at multiple biological levels. The research involves high-throughput analysis of quantitative features from radiology images (radiomics) and digital pathology images...
The National Cancer Institute (NCI) awarded a $256,487 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Sloan-Kettering Institute for Cancer Research. The grant supports a 5-year research project to develop multimodal predictive models that integrate real-world data from circulating tumor DNA sequencing, tumor genomics, medical imaging, and clinical notes to improve risk stratification and clinical management of non-small cell lung cancer (NSCLC). The research aims...
This Project Grant award, provided by the National Cancer Institute under the Cancer Biology Research (CFDA 93.396) program, aims to investigate the biological mechanisms driving racial disparities in outcomes for head and neck cancer, particularly among Black patients. The $714,062 award will fund two main objectives over a period of 5 years: Developing a tailored RNA prognostic model to enhance survival predictions for early-stage oral cancer in Black populations, by identifying gene...
This $680,433 Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to apply cutting-edge spatial proteogenomic technologies and pathology artificial intelligence (PAI) analysis to improve prognostic estimation and understand the underlying biology driving AI outcomes in prostate cancer. The key objectives are to: 1) examine the relationships between established genomic tests and PAI scores in predicting...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to externally validate and integrate radio-pathomic models developed using autopsy and biopsy samples from the Medical College of Wisconsin (MCW) and the University of California, San Francisco (UCSF). The $677,998 award, with a project period from February 1, 2025 to January 31, 2030, will focus on three key objectives: Externally validate...
The National Cancer Institute (NCI) awarded a Project Grant totaling $572,490 to The Regents of the University of California, San Francisco (UCSF) under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The grant, awarded on March 11, 2025, aims to develop an AI-powered tool named PILLAR that can accurately predict breast cancer risk using longitudinal multi-modal breast imaging data, including mammograms, tomosynthesis, and MRIs. The project has three key objectives: 1)...
This $693,156 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program will support the development of artificial intelligence (AI) algorithms to predict prognosis and aid in treatment selection for cutaneous squamous cell carcinoma (CSCC), a highly prevalent form of skin cancer. The research, led by the Dana-Farber Cancer Institute, Inc. in...